HEADER ISOMERASE 03-DEC-09 3KXO TITLE AN ORALLY ACTIVE INHIBITOR BOUND AT THE ACTIVE SITE OF HPGDS COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTATHIONE-REQUIRING PROSTAGLANDIN D SYNTHASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GLUTATHIONE-DEPENDENT PGD SYNTHETASE, PROSTAGLANDIN-H2 D- COMPND 5 ISOMERASE, HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE, H-PGDS; COMPND 6 EC: 5.3.99.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTGDS2, PGDS; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS H-PGDS, PGDS, HPGDS, FATTY ACID BIOSYNTHESIS, ISOMERASE, LIPID KEYWDS 2 SYNTHESIS, PROSTAGLANDIN BIOSYNTHESIS EXPDTA X-RAY DIFFRACTION AUTHOR J.R.KIEFER,J.E.DAY,A.THORARENSEN REVDAT 4 21-FEB-24 3KXO 1 REMARK SEQADV LINK REVDAT 3 01-NOV-17 3KXO 1 REMARK REVDAT 2 21-MAR-12 3KXO 1 HET HETATM HETNAM VERSN REVDAT 1 01-SEP-10 3KXO 0 JRNL AUTH C.P.CARRON,J.I.TRUJILLO,K.L.OLSON,W.HUANG,B.C.HAMPER,T.DICE, JRNL AUTH 2 B.E.NEAL,M.J.PELC,J.DAY,D.C.ROHRER,J.R.KIEFER,J.B.MOON, JRNL AUTH 3 B.A.SCHWEITZER,T.D.BLAKE,S.R.TURNER,R.WOERNDLE,B.L.CASE, JRNL AUTH 4 C.P.BONO,V.M.DILWORTH,C.L.FUNCKES-SHIPPY,B.L.HOOD, JRNL AUTH 5 G.M.JEROME,C.M.KORNMEIER,M.R.RADABAUGH,M.L.WILLIAMS, JRNL AUTH 6 M.S.DAVIES,C.D.WEGNER,D.J.WELSCH,W.M.ABRAHAM,C.J.WARREN, JRNL AUTH 7 M.E.DOWTY,F.HUA,A.ZUTSHI,J.Z.YANG,A.THORARENSEN JRNL TITL DISCOVERY OF AN ORAL POTENT SELECTIVE INHIBITOR OF JRNL TITL 2 HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 21689 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1104 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.16 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1553 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.03 REMARK 3 BIN R VALUE (WORKING SET) : 0.1750 REMARK 3 BIN FREE R VALUE SET COUNT : 92 REMARK 3 BIN FREE R VALUE : 0.2140 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3276 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 95 REMARK 3 SOLVENT ATOMS : 393 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.61000 REMARK 3 B22 (A**2) : -0.51000 REMARK 3 B33 (A**2) : -0.09000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.15000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.265 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.198 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.135 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.982 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.922 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3458 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2306 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4702 ; 1.057 ; 1.979 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5612 ; 0.869 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 394 ; 5.415 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 166 ;35.710 ;24.217 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 584 ;12.650 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;14.763 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 506 ; 0.057 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3804 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 688 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 736 ; 0.200 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2398 ; 0.182 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1702 ; 0.188 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1597 ; 0.082 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 313 ; 0.115 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 2 ; 0.039 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 16 ; 0.120 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 58 ; 0.222 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 36 ; 0.123 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2052 ; 0.598 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 790 ; 0.088 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3230 ; 0.985 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1630 ; 1.177 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1472 ; 1.885 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3KXO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-DEC-09. REMARK 100 THE DEPOSITION ID IS D_1000056576. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-AUG-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC PURPLE MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22810 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06300 REMARK 200 FOR THE DATA SET : 18.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.17 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.19000 REMARK 200 FOR SHELL : 4.850 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM TRIS, PH 8.5, 5MM GLUTATHIONE, REMARK 280 28-34% PEG 3350, 20-200MM MGCL2, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.18200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 63 109.04 71.21 REMARK 500 GLN B 63 107.95 70.03 REMARK 500 ASP B 110 -9.66 72.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP B 110 VAL B 111 148.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 201 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A3097 O REMARK 620 2 HOH A3104 O 85.8 REMARK 620 3 HOH A3112 O 84.8 86.7 REMARK 620 4 HOH B3068 O 92.2 167.5 80.8 REMARK 620 5 HOH B3079 O 172.2 92.5 102.7 91.1 REMARK 620 6 HOH B3116 O 88.9 94.8 173.4 97.5 83.7 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSH A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE KXO A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSH B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE KXO B 203 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2CVD RELATED DB: PDB REMARK 900 HPGDS COMPLEX WITH HQL-79 REMARK 900 RELATED ID: 2VCX RELATED DB: PDB REMARK 900 HPGDS COMPLEX WITH AN INHIBITOR FRAGMENT DBREF 3KXO A 1 199 UNP O60760 PTGD2_HUMAN 1 199 DBREF 3KXO B 1 199 UNP O60760 PTGD2_HUMAN 1 199 SEQADV 3KXO GLY A -2 UNP O60760 INSERTION SEQADV 3KXO SER A -1 UNP O60760 INSERTION SEQADV 3KXO HIS A 0 UNP O60760 INSERTION SEQADV 3KXO GLY B -2 UNP O60760 INSERTION SEQADV 3KXO SER B -1 UNP O60760 INSERTION SEQADV 3KXO HIS B 0 UNP O60760 INSERTION SEQRES 1 A 202 GLY SER HIS MET PRO ASN TYR LYS LEU THR TYR PHE ASN SEQRES 2 A 202 MET ARG GLY ARG ALA GLU ILE ILE ARG TYR ILE PHE ALA SEQRES 3 A 202 TYR LEU ASP ILE GLN TYR GLU ASP HIS ARG ILE GLU GLN SEQRES 4 A 202 ALA ASP TRP PRO GLU ILE LYS SER THR LEU PRO PHE GLY SEQRES 5 A 202 LYS ILE PRO ILE LEU GLU VAL ASP GLY LEU THR LEU HIS SEQRES 6 A 202 GLN SER LEU ALA ILE ALA ARG TYR LEU THR LYS ASN THR SEQRES 7 A 202 ASP LEU ALA GLY ASN THR GLU MET GLU GLN CYS HIS VAL SEQRES 8 A 202 ASP ALA ILE VAL ASP THR LEU ASP ASP PHE MET SER CYS SEQRES 9 A 202 PHE PRO TRP ALA GLU LYS LYS GLN ASP VAL LYS GLU GLN SEQRES 10 A 202 MET PHE ASN GLU LEU LEU THR TYR ASN ALA PRO HIS LEU SEQRES 11 A 202 MET GLN ASP LEU ASP THR TYR LEU GLY GLY ARG GLU TRP SEQRES 12 A 202 LEU ILE GLY ASN SER VAL THR TRP ALA ASP PHE TYR TRP SEQRES 13 A 202 GLU ILE CYS SER THR THR LEU LEU VAL PHE LYS PRO ASP SEQRES 14 A 202 LEU LEU ASP ASN HIS PRO ARG LEU VAL THR LEU ARG LYS SEQRES 15 A 202 LYS VAL GLN ALA ILE PRO ALA VAL ALA ASN TRP ILE LYS SEQRES 16 A 202 ARG ARG PRO GLN THR LYS LEU SEQRES 1 B 202 GLY SER HIS MET PRO ASN TYR LYS LEU THR TYR PHE ASN SEQRES 2 B 202 MET ARG GLY ARG ALA GLU ILE ILE ARG TYR ILE PHE ALA SEQRES 3 B 202 TYR LEU ASP ILE GLN TYR GLU ASP HIS ARG ILE GLU GLN SEQRES 4 B 202 ALA ASP TRP PRO GLU ILE LYS SER THR LEU PRO PHE GLY SEQRES 5 B 202 LYS ILE PRO ILE LEU GLU VAL ASP GLY LEU THR LEU HIS SEQRES 6 B 202 GLN SER LEU ALA ILE ALA ARG TYR LEU THR LYS ASN THR SEQRES 7 B 202 ASP LEU ALA GLY ASN THR GLU MET GLU GLN CYS HIS VAL SEQRES 8 B 202 ASP ALA ILE VAL ASP THR LEU ASP ASP PHE MET SER CYS SEQRES 9 B 202 PHE PRO TRP ALA GLU LYS LYS GLN ASP VAL LYS GLU GLN SEQRES 10 B 202 MET PHE ASN GLU LEU LEU THR TYR ASN ALA PRO HIS LEU SEQRES 11 B 202 MET GLN ASP LEU ASP THR TYR LEU GLY GLY ARG GLU TRP SEQRES 12 B 202 LEU ILE GLY ASN SER VAL THR TRP ALA ASP PHE TYR TRP SEQRES 13 B 202 GLU ILE CYS SER THR THR LEU LEU VAL PHE LYS PRO ASP SEQRES 14 B 202 LEU LEU ASP ASN HIS PRO ARG LEU VAL THR LEU ARG LYS SEQRES 15 B 202 LYS VAL GLN ALA ILE PRO ALA VAL ALA ASN TRP ILE LYS SEQRES 16 B 202 ARG ARG PRO GLN THR LYS LEU HET GSH A 201 20 HET KXO A 202 27 HET MG B 201 1 HET GSH B 202 20 HET KXO B 203 27 HETNAM GSH GLUTATHIONE HETNAM KXO 6-(3-FLUOROPHENYL)-N-[1-(2,2,2-TRIFLUOROETHYL) HETNAM 2 KXO PIPERIDIN-4-YL]PYRIDINE-3-CARBOXAMIDE HETNAM MG MAGNESIUM ION FORMUL 3 GSH 2(C10 H17 N3 O6 S) FORMUL 4 KXO 2(C19 H19 F4 N3 O) FORMUL 5 MG MG 2+ FORMUL 8 HOH *393(H2 O) HELIX 1 1 ALA A 15 LEU A 25 1 11 HELIX 2 2 GLU A 35 ALA A 37 5 3 HELIX 3 3 ASP A 38 LYS A 43 1 6 HELIX 4 4 SER A 44 LEU A 46 5 3 HELIX 5 5 GLN A 63 LYS A 73 1 11 HELIX 6 6 THR A 81 PHE A 102 1 22 HELIX 7 7 LYS A 108 TYR A 122 1 15 HELIX 8 8 TYR A 122 GLY A 136 1 15 HELIX 9 9 THR A 147 LYS A 164 1 18 HELIX 10 10 HIS A 171 ILE A 184 1 14 HELIX 11 11 ILE A 184 ARG A 194 1 11 HELIX 12 12 ALA B 15 LEU B 25 1 11 HELIX 13 13 GLU B 35 ALA B 37 5 3 HELIX 14 14 ASP B 38 SER B 44 1 7 HELIX 15 15 GLN B 63 LYS B 73 1 11 HELIX 16 16 THR B 81 CYS B 101 1 21 HELIX 17 17 VAL B 111 ASN B 123 1 13 HELIX 18 18 ASN B 123 GLY B 136 1 14 HELIX 19 19 THR B 147 LYS B 164 1 18 HELIX 20 20 HIS B 171 ILE B 184 1 14 HELIX 21 21 ILE B 184 ARG B 194 1 11 SHEET 1 A 4 TYR A 29 ILE A 34 0 SHEET 2 A 4 TYR A 4 PHE A 9 1 N TYR A 4 O GLU A 30 SHEET 3 A 4 ILE A 53 VAL A 56 -1 O GLU A 55 N LYS A 5 SHEET 4 A 4 LEU A 59 HIS A 62 -1 O LEU A 59 N VAL A 56 SHEET 1 B 4 GLU B 30 ILE B 34 0 SHEET 2 B 4 TYR B 4 PHE B 9 1 N LEU B 6 O GLU B 30 SHEET 3 B 4 ILE B 53 VAL B 56 -1 O GLU B 55 N LYS B 5 SHEET 4 B 4 LEU B 59 HIS B 62 -1 O LEU B 61 N LEU B 54 LINK O HOH A3097 MG MG B 201 1555 1555 1.96 LINK O HOH A3104 MG MG B 201 1555 1555 2.17 LINK O HOH A3112 MG MG B 201 1555 1555 2.16 LINK MG MG B 201 O HOH B3068 1555 1555 1.94 LINK MG MG B 201 O HOH B3079 1555 1555 2.06 LINK MG MG B 201 O HOH B3116 1555 1555 2.08 CISPEP 1 ILE A 51 PRO A 52 0 11.15 CISPEP 2 ILE B 51 PRO B 52 0 10.18 SITE 1 AC1 14 TYR A 8 ARG A 14 TRP A 39 LYS A 43 SITE 2 AC1 14 LYS A 50 ILE A 51 GLN A 63 SER A 64 SITE 3 AC1 14 KXO A 202 HOH A3001 HOH A3117 HOH A3125 SITE 4 AC1 14 HOH A3137 ASP B 97 SITE 1 AC2 15 PHE A 9 MET A 11 GLY A 13 ARG A 14 SITE 2 AC2 15 GLN A 36 TRP A 39 MET A 99 TRP A 104 SITE 3 AC2 15 TYR A 152 CYS A 156 LEU A 199 GSH A 201 SITE 4 AC2 15 HOH A3111 HOH A3113 HOH A3137 SITE 1 AC3 6 HOH A3097 HOH A3104 HOH A3112 HOH B3068 SITE 2 AC3 6 HOH B3079 HOH B3116 SITE 1 AC4 14 ASP A 97 TYR B 8 ARG B 14 TRP B 39 SITE 2 AC4 14 LYS B 43 LYS B 50 ILE B 51 GLN B 63 SITE 3 AC4 14 SER B 64 KXO B 203 HOH B3010 HOH B3050 SITE 4 AC4 14 HOH B3124 HOH B3126 SITE 1 AC5 11 PHE B 9 MET B 11 ARG B 14 GLN B 36 SITE 2 AC5 11 MET B 99 TRP B 104 TYR B 152 LEU B 199 SITE 3 AC5 11 GSH B 202 HOH B3028 HOH B3121 CRYST1 48.799 78.364 52.455 90.00 91.61 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020492 0.000000 0.000576 0.00000 SCALE2 0.000000 0.012761 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019071 0.00000